The Vigabatrin REMS Program is called for by the FDA to ensure informed risk-benefit decisions before starting treatment, and to guarantee proper use of vigabatrin while clients are treated. When vision loss will take place, it is not possible for your healthcare company to know.
One of the most usual side effect of SABRIL in children 3 to 16 years is weight gain. With severe vision loss, you may only be able to see points right before you (in some cases called tunnel vision"). You are at risk for vision loss with any amount of SABRIL.
Tell your healthcare provider if you are expecting or mean to obtain pregnant. If vision screening can not be done, your doctor may continue prescribing SABRIL, however will certainly not have the ability to expect any type of vision loss. If vision examinations are refrained consistently, your doctor may quit suggesting SABRIL for you (or your youngster).